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Purpose: Continuous sciatic nerve blocks have proven benefits for postoperative analgesia 
after foot surgery. However, the optimal mode of administration remains a point of debate. 
Ultrasound guided subparaneural injection accelerates onset time and increases duration after 
a single shot sciatic nerve block. This double blind prospective randomized trial compares 
the 48-hour local anesthetic (LA) dose consumption of an automated intermittent bolus 
technique to a continuous infusion regimen in a subparaneural sciatic nerve catheter after 
hallux valgus surgery.
Patients and Methods: Patients scheduled for hallux valgus surgery were randomized to 
receive either a continuous infusion of levobupivacaine 0.125% at 5mL/h (group A) or an 
intermittent automated bolus of 9.8 mL every 2 hours with a background of 0.1 mL/h (group 
B), both with a PCA bolus of 6 mL and lockout of 30 minutes. The 48 hour LA consumption, 
PCA boluses, Numeric Rating Scale (NRS), satisfaction and return of normal sensation were 
recorded.
Results: Sixteen patients were excluded because of protocol violation or technical problems 
and 42 patients remained for analysis. The 48 hour ropivacaine consumption was higher in 
group A (293 ±60 mL) than group B (257±33 mL). The median and highest NRS scores and 
patient satisfaction were not statistically different between groups. Normal sensation returned 
after 75 ± 22 hours (group A) and 70 ± 17 hours (group B).
Conclusion: Programmed bolus administration in subparaneural sciatic nerve catheters 
reduces LA consumption 48 hours after surgery with equal analgesia and patient satisfaction. 
Return of sensation is variable and can last more than 75 hours.
Keywords: locoregional anesthesia, sciatic nerve block, postoperative pain, local 
anesthetics, levobupivacaine, orthopedic surgery
Introduction
Continuous sciatic nerve blocks have proven benefits for postoperative analgesia 
after foot and ankle surgery.1–4 However, the optimal mode of administering local 
anesthetic (LA) remains a point of debate. Several studies have been performed 
looking at the best volume, dose, concentration, and administration technique of 
local anesthetics.5,6 Theoretically, the optimal LA dose for sciatic nerve catheters 
provides good analgesia with minimal motor block, no disturbing numbness, low 
risk of local anesthetic systemic toxicity and a low threshold for detecting compart-
ment syndrome.
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With the development of technology, it has become 
possible to administer more sophisticated LA regimens 
such as programmed intermittent bolus administration 
(PIB). The epidural use of PIB has been shown to reduce 
the need for LA during labor.7 However, its potential 
benefit in reducing LA need for satisfactory analgesia in 
orthopedic interventions is less established.
In this prospective double-blind randomized trial, we 
aimed to investigate whether the application of the PIB 
technique allowed a reduced administration of LA during 
a subparaneural sciatic nerve block for orthopedic foot 
surgery. We hypothesized that with PIB, less LA would 
be needed during the first 48 hours after surgery to obtain 
adequate postoperative analgesia (NRS<4) compared to 
continuous infusion combined with patient-controlled 
analgesia (PCA). The primary outcome variable was LA 
consumption during the first 48 hours after connecting the 
peripheral nerve catheter. Secondary outcomes were pain 
scores, motor and sensory block, numbness, patient satis-
faction and rescue analgesia. The return of sensory func-
tion after removal of the catheter was also assessed.
Patients and Methods
This single-institution, prospective, double-blind rando-
mized trial design was approved by the Hospital Ethics 
Committee of the University Hospital Antwerp and was 
registered at clinical.trials.gov NCT02293330. The trial 
was conducted in accordance with the Declaration of 
Helsinki.
Foot surgery of the metatarsophalangeal (MTP) joint 
(Scarf-Akin, Keller, MTP arthrodesis, Weil osteotomy, 
Hoffmann resection) at the Antwerp University Hospital 
is performed under general anesthesia with a popliteal 
nerve catheter for postoperative analgesia. All patients, 
aged ≥18 years, undergoing such surgery were asked to 
take part and give informed consent. Patients with neuro-
muscular diseases, peripheral neuropathy in the lower 
limb, chronic pain or any contraindication for a sciatic 
nerve block in their medical history were excluded.
The anesthesiologist performing the block, the patient 
and the independent observer were unaware of the study 
group. The data and observations were collected at the 
ward by a study nurse, who also collected the data out of 
the PCA pump after 48 hours.
Patients were randomized by a computer-generated 
sequence and concealed in sealed envelopes to either 
a continuous infusion of LA (group A) or to the PIB 
group (group B). The envelope was opened, and the 
pump prepared by an independent anesthesiologist who 
did not participate in registration of the parameters.
At arrival in the preparation room, an IV access was 
established, and standard monitoring was applied (blood 
pressure, ECG, and pulse oximetry).
An experienced anesthesiologist performed all the 
blocks in the lateral decubitus position with a 12–18 
MHz linear probe (BK medical) and a Pajunk SonoLong 
needle/catheter set (18-gauge needle, 20-gauge catheter).
The nerve was visualized in a short axis image and the 
paraneurium was pierced at the exact junction of the 
peroneal and tibial nerve where they are adjacent but still 
can be distinguished in the ultrasound image to prevent 
intraneural injection with an out of plane technique as seen 
in Figure 1.
Confirmation of accurate needle tip position was con-
firmed by injection of NaCl 0.9% between the peroneal 
and tibial nerve in the paraneural sheath (Figure 2).
After confirmation of correct needle tip position, 
15 mL levobupivacaine 0.25% was injected in between 
the peroneal and tibial nerve as a single location injection 
technique with intermittent aspiration every 5 mL to pre-
vent intravascular injection. After injection, a catheter was 
advanced 4 cm beyond the needle tip.
The location of the catheter tip was checked with 
ultrasound in short and long axis with the guide wire still 
in place and with a bolus of NaCl 0.9% after removing the 
guide wire. When correct catheter placement could not be 
confirmed, the patient was excluded from the study. The 
depth of the catheter and time of local anesthetic injection 
was registered. The sensory block of the peroneal and 
tibial nerve was separately tested by loss of cold sensation 
at the dorsal and plantar side of tows before transfer to the 
Figure 1 Out of plane puncture at the division of the tibial and peroneal nerve.
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operating room, at least 20 minutes after the initial injec-
tion of levobupivacaine 0.25%. When no block was 
detected it was considered as a block failure and the 
patient was excluded from the study.
General anesthesia with a laryngeal mask was per-
formed with propofol and sufentanil and maintained by 
sevoflurane and sufentanil increments. Surgery was per-
formed with a tourniquet at 300 mm Hg at the upper thigh. 
Duration of surgery was registered.
After surgery, patients were transferred to the recovery 
room. Here the infusion of the sciatic nerve catheter was 
initiated according to the study group by an independent 
anesthesiologist:
Group A: continuous infusion of levobupivacaine 
0.125% at 5 mL/h. Optional patient-controlled bolus dose 
6 mL, lock out 30 minutes, 4 hours limit: 60 mL/h.
Group B: intermittent bolus of levobupivacaine 
0.125%: 0.1 mL/h and 9.8 mL bolus every 2 hours. 
Optional patient-controlled bolus dose 6 mL, lock out 30 
minutes, 4 hours limit: 60 mL/h.
The first intermittent bolus was programmed 15 min-
utes after catheter connection.
The Pump (CADD Smiths medical) was started in the 
recovery room by an anesthesiologist who was aware of 
the appointed study group (group A or group B). Standard 
monitoring (ECG, pulse oximetry and non-invasive blood 
pressure) was applied and pain scores on an NRS 
(Numeric Rating Scale) were registered every 30 minutes 
during recovery. Motor block (movement of toes yes or 
no), sensory block (loss of cold sensation at the dorsal 
(peroneal nerve) and plantar side (tibial nerve) of the tows) 
and the presence of numbness were registered (subjective 
feeling of numbness yes/no) for the first time when 
patients were sufficiently awake enough to evaluate these 
parameters.
Patients were transferred to the ward after clear instruc-
tions on how to use the pain pump. Pain scores were 
registered every 4 hours on the ward.
When pain control was insufficient (NRS>3) at the 
recovery room or on the ward, patients received paraceta-
mol 1gr IV and ketorolac 30 mg IV. Tramadol IV 2 mg/kg 
was given as rescue analgesia. All medication was regis-
tered. On the ward, the presence of a motor block (defined 
as possibility of toe movement yes or no), sensory block 
(tested by cold sensation at the dorsum and plantar side of 
the tows) and the sensation of numbness (0=no, 1=yes but 
non-disturbing 2=yes and disturbing) were registered at 6, 
12, 24, 30.36 and 48 hours after starting the pump.
The pain pump was stopped after exactly 48 hours and 
all data were collected and filed. This file consisted of 
a detailed description of the history log of LA adminis-
tered, like total LA dose in mL and mg, frequency and 
time of extra boluses required.
After stopping the pump, the patient was asked if he or 
she was satisfied using a satisfaction scale score (1: very 
unsatisfied 10: very satisfied).
The patient was asked to register the exact time point 
where he or she experienced that the numb feeling dis-
appeared, and normal sensation returned. The patient was 
called 2 days after discharge to register these parameters.
Statistical Analysis
We considered a 20% difference in LA dose between 
groups as a clinically relevant difference. We used 
a standard deviation of 25% (58 mg) based on data 
obtained from a previous study.8 The calculated minimum 
sample size required was 20 patients per group for a power 
of 80% with a 2-tailed significance level of 5%.
Statistical analysis was performed with IBM SPSS 
statistics for mac version 23. Data distributions were tested 
with a Kolmogorov–Smirnov test. For normally distribu-
ted data, groups were compared with a Student’s T-test. 
Non-normally distributed data were compared with 
a Mann–Whitney U-test. Categorical data distributions 
were compared with a Χ-square test.
Figure 2 Injection of fluid in between the tibial (T) and peroneal (P) nerve.
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Results
From December 2014 to May 2016, 168 patients were 
screened, and 58 patients were randomized after giving 
informed consent. Four patients were not randomized 
because of poor visualization of the catheter. Fourteen 
patients were excluded after randomization due to protocol 
violation, catheter-related problems or lost data of the 
pump and 42 patients remained for analysis (Figure 3). 
Demographic data, the time interval between the block and 
the start of the pump and depth of the catheter were 
comparable and are presented in Table 1.
LA consumption is shown in Table 2. Total LA dose 
consumption was significantly higher for group A (293 
±60 mL) compared to Group B (257 ± 33 mL). 
However, the amount of patient-controlled analgesia did 
not differ between groups. In 21 out of 23 patients, several 
programmed boluses were postponed because they fell in 
the lock out window of 30 minutes after a PCA bolus. 
Figure 3 Flow diagram in conductance with the Consolidated Standards of Reporting trials (CONSORT).
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There was no difference in the distribution of PCA 
requests between groups.
Motor and sensory block characteristics at the time 
of catheter removal after 48 hours are displayed in 
Table 3.
A sensory block was present in both peroneal and tibial 
sensory area in 59% (group A) and 50% (Group B) of the 
cases.
The majority of the patients were able to move their 
toes at 12, 24, 30, 36 and 48 hours after starting the pump. 
There were no statistical differences in motor block at any 
time point between groups. The number of patients that 
experienced numbness was 64% in both groups. Only one 
patient in Group A experienced this numbness as 
disturbing.
Patient satisfaction and NRS scores are displayed in 
Table 4. The median NRS scores over 48 hours and the 
highest NRS scores were equally distributed in both 
study groups. The median satisfaction was high 
(9.5–10) in both groups. No additional analgesia was 
adminstered in the recovery room. On the ward 16 
patients in group Areceived extra paracetamol and 
ketorolac. In group B 13 patients received additional 
doses of paracetamol and ketorolac in this 48-hour per-
iod. In both groups, 8 patients needed additional trado-
nal. Total doses of extra analgesia are displayed in 
Table 4.
Many patients had to be called again because normal 
sensation did not return after 2 days. Sensation returned 
after 70 ±17 hours in group B and 75 ±22 hours in Group 
A. There were no signs of neurologic deficit in any patient 
at follow-up.
Discussion
In this study, we hypothesized that a targeted bolus admin-
istration of LA within the confined subparaneural anato-
mical space would allow for a lower LA consumption 
compared to administration in a continuous infusion 
mode. The suggested mechanism for an LA dose reduction 
in PIB is a higher injection pressure and less systemic 
uptake by which more neural tissue is reached.9
Taboada et al published two similar randomized trials 
comparing intermittent bolus versus continuous infusion in 







Weight (kg) 63 (11) 71 (14) 0.3
Length (cm) 166 (6) 168 (8) 0.4
Age (years) 52 (14) 54 (15) 0.7
Catheter depth (cm) 9 (0.6) 9 (0.7) 0.9
Time from injection-start 
pump (min)
110 (28) 104 (24) 0.4
Notes: Data are presented as mean (sd). Group A= continuous group, group 
B=intermittent bolus group.







Total LA (mL) 293 (60) 257 (33) 0.02
PCA LA (mL) 53 (13) 75 (89) 0.06
Intermittent bolus LA (mL) 0 178 (60)
Continuous LA (mL) 240 (0.3) 4.8
Notes: Data are presented as mean (sd). Group A= continuous group, group 
B=intermittent bolus group. 
Abbreviation: PCA, patient-controlled analgesia.







Group A Group B P-value
% motor block 21% 29% ns
% sensory block tibial 
area
11% 18% ns
% sensory block 
peroneal area
17% 27% ns
% sensory block both 
areas
59% 50% ns
Notes: Data are represented as percentages (%). Group A= continuous group, 
group B=intermittent bolus group. 
Abbreviation: ns, nonsignificant.







Highest NRS score mean (min-max) 5 (0–9) 3 (0–8) ns
Patient satisfaction median (min-max) 10 (7–10) 10 (2–10) ns
Total doses IV paracetamol (1000mg) 
and IV ketorolac (30mg)
30 28 ns
Total doses of IV tradonal (2 mg/kg) 8 8 ns
Notes: (0=no pain, 10=worst pain), and patient satisfaction (1=very dissatisfied 
10=very satisfied). Data are expressed as median (min-max). Group A= continuous 
group, group B=intermittent bolus group. 
Abbreviation: ns, nonsignificant.
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sciatic nerve catheters. Although the catheters in these 
trials were placed by neurostimulation, they found similar 
results in LA and pain score reduction.8,10
Our trial confirms a comparable reduction of local 
anesthetic dose by using the PIB technique. However, 
ultrasound implies a more accurate placement of the cathe-
ter compared to neurostimulation.11 Therefore, we 
expected a more pronounced difference compared to sti-
mulation and more extensive local anesthetic spread 
within this defined sheat as described by Perlas et al with 
a single shot technique within the paraneurium.12 The LA 
doses and pain scores in our trial were however compar-
able to those of Taboada.8,10 Neither could we find differ-
ence in the percentage of the tibial and peroneal nerve 
block, implying more extensive local anesthetic spread.
Sztain et al compared a continuous infusion in cathe-
ters placed underneath the paraneurium with catheters 
placed superficial of the paraneurium. She also failed to 
demonstrate any advantages in pain scores, analgesic con-
sumption or feeling of numbness by placing the catheter 
underneath the paraneural sheath.13
We hypothesize that the lack of LA reduction for 
a catheter placed inside the paraneural sheath could be 
explained due to a different local anesthetic uptake when 
injecting inside the paraneurium compared to injecting to 
the surrounding structures which contain more fat tissue 
and could function as a local anesthetic depot.14
Previous trials postulate that LA dose instead of 
volume is the only determining factor for LA need in 
a continuous infusion.15,16 However, the doses used in 
these trials were considerably higher compared to our 
trial, and differences might be more pronounced with 
lower doses.
A recent meta-analysis investigating the benefit of the 
PIB technique for peripheral and truncal nerve analgesia 
was unable to draw any data-driven conclusions towards 
preferable anesthetic delivery method.9
The question rises if a reduction of 45 mg levobupiva-
caine in 48 hours is clinically relevant. Since the dose 
given in 48 hours does not differ much with the maximum 
recommended dose for a single shot popliteal nerve block, 
the authors shared opinion is that concerning local anes-
thetic systemic toxicity (LAST) this reduction is not clini-
cally relevant. Any differences in patient satisfaction, 
motor block or disturbing numbness as a result of the 
45 mg dose reduction could not be demonstrated in this 
trial. However, concerning the detection of compartment 
syndrome and the risk of neurotoxicity, there is 
a consensus that “ less is better” especially since the 
catheter is placed in close proximity to the nerves within 
the paraneurium.17,18 However, the optimal dose/concen-
tration has yet to be determined.
The mean return of normal sensation was 72 hours. Not 
much information is available in the literature concerning 
the duration of sensory block after removal of a sciatic 
nerve catheter. However, after a single shot, de duration of 
analgesia varies between 6 and 20 hours, depending on the 
dose, kind of local anesthetic, the additives used and the 
presence of diabetes.19–21 There are no trials investigating 
the duration of the sensory block after catheter removal. In 
our trial, the mean duration of sensory block after catheter 
removal seems substantially longer than generally 
assumed based on the theoretical duration of action of 
levobupivacaine.
The results of the present study should be interpreted 
within the constraints of the methodology used.
The safety of this technique could be debatable because 
of the risk of neural damage with the placement of the 
catheter within the paraneural sheath.22,23 All our patients 
resumed normal motor and sensory function within 7 days.
We did not give the initial bolus dose through the 
catheter, what could confirm correct catheter placement 
according to some authors.24 The failure rate of catheter 
placement by stimulation is as high as 10–40%.25 Data 
produced by a stimulation technique are not automatically 
applicable to an ultrasound technique.26
A 20% increase in success rate was shown with ultra-
sound placement of popliteal catheters in a previous study 
and the probability of catheter dislodgement diminishes by 
placing it longitudinal to the nerve.27,28 However, we did 
not reconfirm correct catheter placement after surgery or 
on the ward. This means that we could have missed 
catheter dislodgement.
Several programmed boluses were postponed because 
they fell in the lock out window of 30 minutes after a PCA 
bolus.
We used levobupivacaine as loading dose which could 
mask a bigger difference between the two techniques the 
first 8–12 hours.
Furthermore, there might be more factors that influence 
the success of a postoperative continuous sciatic nerve 
catheter such as catheter orifice configuration or other yet 
unknown factors.29 We placed the catheter in an out-of- 
plane technique with a single end hole and used a dose 
regimen based on stimulation placed catheters. There are 
no solid data on dose regimens, catheters and optimal 
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placement techniques, therefore changing one of these 
factors might change the outcome of this study.
Conclusion
In conclusion, programmed intermittent bolus administra-
tion with levobupivacaine 0.125% in a subparaneural scia-
tic catheter provided a dose reduction of 45 mg compared 
with a continuous infusion technique. The subparaneural 
placement of the catheter did not cause any complications 
or neural deficit and return of normal sensation after 
catheter removal is longer than expected. More research 
is needed to identify the optimal dose, volume, and time 
interval for this regimen.
Data Sharing Statement
Data are available on request to the corresponding author.
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